Patients with chronic spontaneous urticaria experienced early symptom improvements that were sustained through 52 weeks with remibrutinib, according to a presentation at the European Academy of Allergy & Clinical Immunology Congress. The safety profile for the Bruton’s tyrosine kinase (BTK) inhibitor was favorable and consistent through 52 weeks as well, the researchers said.
As Lyme disease cases increase, so does promise of a new vaccine healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
Threat of antimicrobial resistance on the rise in low-, middle-income countries healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
Spectral-domain OCT among top modalities to quantify diabetic retinal disease healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
Psilocybin hailed as 'potential breakthrough' for depression among patients with cancer healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.